- Home
- IVT vs RARE Comparison
IVT vs RARE Comparison
Compare IVT & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVT | RARE |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.3B |
| IPO Year | 2005 | 2013 |
Fundamental Metrics
Financial Performance| Metric | IVT | RARE |
|---|---|---|
| Price | $30.76 | $21.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 19 |
| Target Price | $32.20 | ★ $66.32 |
| AVG Volume (30 Days) | 434.8K | ★ 1.9M |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.24% | N/A |
| EPS Growth | ★ 647.37 | 7.31 |
| EPS | ★ 1.42 | N/A |
| Revenue | $299,169,000.00 | ★ $673,000,000.00 |
| Revenue This Year | $8.47 | $13.40 |
| Revenue Next Year | $5.93 | $42.83 |
| P/E Ratio | $21.73 | ★ N/A |
| Revenue Growth | 9.20 | ★ 20.13 |
| 52 Week Low | $25.21 | $18.41 |
| 52 Week High | $31.91 | $40.21 |
Technical Indicators
Market Signals| Indicator | IVT | RARE |
|---|---|---|
| Relative Strength Index (RSI) | 55.06 | 42.73 |
| Support Level | $30.37 | $19.61 |
| Resistance Level | $31.71 | $25.46 |
| Average True Range (ATR) | 0.58 | 0.80 |
| MACD | -0.10 | 0.10 |
| Stochastic Oscillator | 30.84 | 36.73 |
Price Performance
Historical ComparisonAbout IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.